Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Human immortalized lymphocyte cell line (immortalized by EBV) | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | M. Pradas-Juni et al., Mol. Endocrinoly, 2014, 28(9): 1558-1570, doi: 10.1210/me.2014-1065 | Link | |||
Mouse immortalized differentiated podocytes | Mouse | urinary system | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | J. G. Greiten et al., The FASEB Journal, 2021, 35: e21560, DOI: 10.1096/fj.202001179RR | Link | |||
Human primary fibroblasts (derived from ALS patients) | Human | unknown | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Milani et al., J. of Neuroinflammation, 2021, 18: 132, doi.org/10.1186/s12974-021-02184-1 | Link | |||
143B |
Human osteosarcoma cell line | ATCC CRL-8303 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | V. R. Lo Vasco et al., J. Cell Commun. Signal., 2015, 9:55-62; DOI 10.1007/s12079-015-0265-y | ||
143B |
Human osteosarcoma cell line | ATCC CRL-8303 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Leopizzi., PhD Thesis, 2018, University of Rome | Link | |
143B |
Human osteosarcoma cell line | ATCC CRL-8303 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | V. R. L. Vasco et al., J. Cell Commun. Signal, 2014, 8:219-229, DOI 10.1007/s12079-014-0235-9 | Link | |
143B |
Human osteosarcoma cell line | ATCC CRL-8303 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | V. R. Lo Vasco et al., Anticancer Res, Aug 2014; 34: 4069 - 4075 | ||
1BR-hTERT |
Human hTERT-immortalized skin fibroblasts | Human | skin | cell line | siRNA | RNA-Interference | Metafectene PRO | publication | C. Kerzendorfer et al., Hum. Mol. Genet., Apr 2010; 19: 1324 - 1334 | Link | |||
1BR-hTERT |
Human hTERT-immortalized skin fibroblasts | Human | skin | cell line | siRNA | RNA-Interference | Metafectene PRO | publication | H. Brunton et al., Mol. Cell. Biol., Oct 2011; 31: 4022 - 4035 | Link | |||
1BR.3 |
Human primary fibroblasts | Human | unknown | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Abramowicz ez al., HMG Advance Access, 2016 | |||
293-TLR3 |
Human embryonic kidney cell line stably expressing TLR3 (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | R. Higgs et al., J. Immunol., Aug 2008; 181: 1780 - 1786 | Link | ||
293-TLR4/MD2 |
Human embryonic kidney cell line stably expressing TLR4/MD2 (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | R. Higgs et al., J. Immunol., Aug 2008; 181: 1780 - 1786 | Link | ||
293A |
Human embryonic kidney adenovirus producer cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | H. Qiu et al., Cell Death and Differentiation, 2016, 23: 1658-1669, doi:10.1038/cdd.2016.56 | Link | ||
293A |
Human embryonic kidney adenovirus producer cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. D. Konitsiotis et al., PLoS ONE, 2014, 9(3): e89899, doi:10.1371/journal.pone.0089899 | Link | ||
293A |
Human embryonic kidney adenovirus producer cell line (derivat of HEK293) | DSM ACC 305 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | W. Kim et al., J. Biol. Chem., 287 (8): 5278–5289, DOI 10.1074/jbc.M111.281709 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K.-C. Woo et al., FASEB J, Aug 2011; 25: 2757 - 2769 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Kim et al., Nature Communications, 2019, 10:4898, doi.org/10.1038/s41467-019-12910-2 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | D. Konina et al., Int. J. Mol. Sci., 2021, 22, 8477, doi.org/10.3390/ijms22168477 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | J. Galán‐Martínez et al., Mol. Oncology, 2021, doi:10.1002/1878-0261.13085 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. D. Amsel et al., PNAS, Apr 2008; 105: 5117 - 5122 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | Z. Mbita et al., Mol. Cell. Biochem., 2012, 362: 249–262, DOI 10.1007/s11010-011-1150-5 | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | R. Domínguez-Kelly et al., J. Cell Biol., Aug 2011; 194: 567 - 579 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | miRNA | RNA-Interference | K2 Transfection System | publication | V. Burghi et al., Front. Pharmacol., 2019, 10: 146, doi: 10.3389/fphar.2019.00146 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | R. Higgs et al., J. Immunol., Aug 2008; 181: 1780 - 1786 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | RNA-Interference | Metafectene EASY | publication | Z. Mbita et al., Mol. Cell. Biochem., 2012, 362: 249–262, DOI 10.1007/s11010-011-1150-5 |